SMAD3 and gastric cancer: MiR-204 inhibits the phosphorylation of SMAD2 and SMAD3 by directly targeting TGF-β receptor 2, which further contributes to the inhibition of EMT and elevates the sensitivity to 5-fluorouracil in gastric cancer cells [33].